Princeton University-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Princeton University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014172
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Princeton University (Princeton) is a research university that provides undergraduate and graduate instruction. The university offer education in the areas of humanities, social sciences, natural sciences and engineering. It provides services such as health services, event planning, external affairs, information technology, safety and preparedness, transportation and parking, business systems, finance and purchasing, and legal policies. Princeton operates with academic departments and centers. It offers interdisciplinary undergraduate certificate programs. The university also offers scholarship and master’s degree programs in architecture, engineering, finance, and public affairs, among others. Princeton is headquartered in Princeton, New Jersey, the US.

Princeton University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Princeton University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Princeton University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Princeton University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Princeton University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Princeton University, Medical Devices Deals, 2011 to YTD 2017 9
Princeton University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Princeton University, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Princeton University Acquires LAESI DP-1000 Instrument System from Protea Biosciences 11
Partnerships 12
Nevakar Enters into Research Agreement with Princeton University 12
Bristol-Myers Squibb Enters into Research Agreement with Princeton University 13
Thermo Fisher Enters Into An Agreement With Princeton University 14
Licensing Agreements 15
Forge Life Science Enters into Licensing Agreement with Princeton University 15
Princeton University – Key Competitors 16
Princeton University – Key Employees 17
Princeton University – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Government and Public Interest 19
May 22, 2017: New Jersey Health Foundation Awards $50,000 Innovation Grant To Princeton University Researchers Studying Metastatic Cancer Cells 19
May 22, 2017: Study identifies RNA molecule that shields breast cancer stem cells from immune system 20
Oct 27, 2016: New Jersey Health Foundation Awards $50,000 Innovation Grant To Princeton University Researcher Working to Manipulate Cellular DNA for Improved Disease Treatments 21
Sep 22, 2016: Kenneth Rainin Foundation Awards Over $3 Million to High-Risk, High Reward Inflammatory Bowel Disease Research Projects 22
Sep 06, 2016: New Jersey Health Foundation Commits $1 Million To Fund Latest Cycle of Research Grants Program 24
Feb 18, 2016: Ebola crisis provides framework for responding to outbreaks like Zika virus 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Princeton University, Pharmaceuticals & Healthcare, Key Facts 2
Princeton University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Princeton University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Princeton University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Princeton University, Deals By Therapy Area, 2011 to YTD 2017 8
Princeton University, Medical Devices Deals, 2011 to YTD 2017 9
Princeton University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Princeton University Acquires LAESI DP-1000 Instrument System from Protea Biosciences 11
Nevakar Enters into Research Agreement with Princeton University 12
Bristol-Myers Squibb Enters into Research Agreement with Princeton University 13
Thermo Fisher Enters Into An Agreement With Princeton University 14
Forge Life Science Enters into Licensing Agreement with Princeton University 15
Princeton University, Key Competitors 16
Princeton University, Key Employees 17
Princeton University, Subsidiaries 18

★海外企業調査レポート[Princeton University-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • XState Resources Ltd (XST):石油・ガス:M&Aディール及び事業提携情報
    Summary XState Resources Ltd (XState Resources) is an oil and gas exploration and development company. The company’s business activities include acquisition, exploration, production and development of oil and gas assets. It holds interest in producing gas wells and associated land leases and product …
  • Lamar Advertising Company (LAMR):企業の財務・戦略的SWOT分析
    Lamar Advertising Company (LAMR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Credit Saison Co., Ltd.:企業の戦略・SWOT・財務分析
    Credit Saison Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Credit Saison Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Fujitsu Australia Ltd:企業の戦略的SWOT分析
    Fujitsu Australia Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Lea County Electric Cooperative Inc:企業の戦略的SWOT分析
    Lea County Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Key Energy Services, Inc. (KEG)-石油・ガス分野:企業M&A・提携分析
    Summary Key Energy Services, Inc. (Key) is an onshore, rig-based well servicing contractor, which offers a range of rig services. Its service line includes rig-based and coiled tubing-based well maintenance and workover services, well completion and recompletion services, fluid management services, …
  • Century Enka Limited:企業の戦略・SWOT・財務分析
    Century Enka Limited - Strategy, SWOT and Corporate Finance Report Summary Century Enka Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Agfa HealthCare NV-医療機器分野:企業M&A・提携分析
    Summary Agfa HealthCare NV (Agfa HealthCare) a subsidiary of Agfa-Gevaert NV is a healthcare technology company that develops, produces and distributes analog and digital imaging systems and information technology solutions. The company operates through diagnostic imaging, enterprise imaging, integr …
  • GEN energija, d.o.o.:企業の戦略的SWOT分析
    GEN energija, d.o.o. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • BMO Capital and Income Investment Trust PLC:企業の戦略・SWOT・財務情報
    BMO Capital and Income Investment Trust PLC - Strategy, SWOT and Corporate Finance Report Summary BMO Capital and Income Investment Trust PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Option NV (OPTI):企業の財務・戦略的SWOT分析
    Option NV (OPTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • SARIA AS GmbH & Co KG:企業の戦略的SWOT分析
    SARIA AS GmbH & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • SuppreMol GmbH-製薬・医療分野:企業M&A・提携分析
    Summary SuppreMol GmbH (SuppreMol), a subsidiary of Baxalta Inc, is a biopharmaceutical company that develops therapeutics in the areas of autoimmune, chronic inflammatory diseases, and allergies. The company’s lead drug candidate is extensively profiled in in-vitro, ex-vivo and in-vivo experiments. …
  • Exact Sciences Corp (EXAS):企業の製品パイプライン分析2018
    Summary Exact Sciences Corp (Exact Sciences) is a molecular diagnostic company that focuses on the early detection and prevention of various types of cancers. The company’s flagship product, Cologuard test is a non-invasive stool-based deoxyribonucleic acid (DNA) screening product indicated for the …
  • MedinCell SA:製薬・医療:M&Aディール及び事業提携情報
    Summary MedinCell SA (MedinCell) is a developer of therapeutic solutions for the healthcare market. The company develops and commercializes BEPO, a technology based on custom proprietary copolymers and a biocompatible solvent for long acting injectables. Its BEPO provides a controlled release of the …
  • Ayala Corp (AC):企業の財務・戦略的SWOT分析
    Ayala Corp (AC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Nigerian National Petroleum Corporation-石油・ガス分野:企業M&A・提携分析
    Summary Nigerian National Petroleum Corporation (NNPC) is a state-owned vertically integrated oil and gas company, which explores for, produces, markets and distributes crude oil, refined petroleum and associated by-products. It operates through a network of refineries that produce products such as …
  • Caspian Sunrise Plc (CASP):石油・ガス:M&Aディール及び事業提携情報
    Summary Caspian Sunrise Plc (Caspian), formerly Roxi Petroleum plc, is an oil and gas exploration and development company. The company acquires, explores and develops crude oil. It holds interests in the exploration and production of BNG contract area in the Pre-Caspian basin and the Mangyshlak basi …
  • ICF International, Inc.:企業の戦略・SWOT・財務情報
    ICF International, Inc. - Strategy, SWOT and Corporate Finance Report Summary ICF International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Optiscan Imaging Limited (OIL)-医療機器分野:企業M&A・提携分析
    Summary Optiscan Imaging Limited (Optiscan) is a technology and product development company. It focuses on the development and application of microscopic imaging technologies for medical procedures. The company’s key product is ViewnVivo, a miniaturized fluorescence endo-microscope platform that bri …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆